QUERCIOLI, ALESSANDRA MARIA
 Distribuzione geografica
Continente #
EU - Europa 7.332
AS - Asia 710
NA - Nord America 670
Continente sconosciuto - Info sul continente non disponibili 100
SA - Sud America 91
AF - Africa 15
Totale 8.918
Nazione #
IT - Italia 7.205
US - Stati Uniti d'America 602
SG - Singapore 304
CN - Cina 157
VN - Vietnam 115
BD - Bangladesh 63
FR - Francia 59
BR - Brasile 57
FI - Finlandia 19
CA - Canada 18
HK - Hong Kong 16
AR - Argentina 14
DE - Germania 13
JP - Giappone 11
IN - India 10
JM - Giamaica 10
GB - Regno Unito 9
MX - Messico 9
CH - Svizzera 6
PR - Porto Rico 6
CO - Colombia 5
CR - Costa Rica 5
HN - Honduras 5
IQ - Iraq 5
NL - Olanda 5
EC - Ecuador 4
GT - Guatemala 4
JO - Giordania 4
PK - Pakistan 4
TW - Taiwan 4
CL - Cile 3
DZ - Algeria 3
PH - Filippine 3
RU - Federazione Russa 3
SA - Arabia Saudita 3
VE - Venezuela 3
ZA - Sudafrica 3
BY - Bielorussia 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
ID - Indonesia 2
KZ - Kazakistan 2
MY - Malesia 2
PT - Portogallo 2
PY - Paraguay 2
SV - El Salvador 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
BB - Barbados 1
BO - Bolivia 1
BZ - Belize 1
DO - Repubblica Dominicana 1
ES - Italia 1
GM - Gambi 1
GP - Guadalupe 1
HR - Croazia 1
IE - Irlanda 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
LC - Santa Lucia 1
MA - Marocco 1
MM - Myanmar 1
NA - Namibia 1
NG - Nigeria 1
NI - Nicaragua 1
PE - Perù 1
PL - Polonia 1
RS - Serbia 1
SE - Svezia 1
UA - Ucraina 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
Totale 8.818
Città #
Genova 4.688
Genoa 1.598
Vado Ligure 445
Rapallo 396
San Jose 182
Singapore 151
Ashburn 64
Lauterbourg 52
Ho Chi Minh City 35
Beijing 30
Hanoi 28
New York 22
Helsinki 19
Santa Clara 17
Bordighera 14
Hong Kong 14
Council Bluffs 11
Frankfurt am Main 11
Los Angeles 10
Chicago 9
Mexico City 9
Tokyo 9
Kansas City 7
Buffalo 6
Da Nang 6
Dallas 6
Milan 6
Zurich 6
Kingston 5
Orem 5
Amman 4
Bologna 4
Guatemala City 4
Naples 4
Phoenix 4
Rome 4
San Antonio 4
San José 4
Seattle 4
São Paulo 4
Atlanta 3
Biên Hòa 3
Chennai 3
City of London 3
Guayaquil 3
Las Vegas 3
Metairie 3
Montreal 3
San Carlo Canavese 3
Addis Ababa 2
Alpharetta 2
Amsterdam 2
Anchorage 2
Baghdad 2
Belo Horizonte 2
Braham 2
Brentwood 2
Brooklyn 2
Calgary 2
Charlotte 2
Clarksville 2
Clinton Township 2
Des Moines 2
East Orange 2
Florence 2
Glendale 2
Greensboro 2
Guarulhos 2
Haiphong 2
Houston 2
Iowa City 2
Jacksonville 2
Johannesburg 2
Jonesboro 2
Karachi 2
Kaunakakai 2
Manlius 2
Marion 2
Mayagüez 2
Miami 2
Minneapolis 2
Monroe 2
Newark 2
Orlando 2
Pflugerville 2
Princeton 2
Quận Ba 2
Rialto 2
Richmond 2
Rio de Janeiro 2
Riverside 2
Rochester 2
San Francisco 2
San Mateo 2
San Pedro Sula 2
San Salvador 2
Shanghai 2
Spokane 2
São José do Rio Preto 2
Taipei 2
Totale 8.030
Nome #
Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome. 285
Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways. 234
The vulnerable coronary plaque: update on imaging technologies. 232
Clorhexidine prevents hypoclorous acid-induced inactivation of alpha1-antitrypsin. 222
CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke. 206
Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity. 206
Improvement in coronary circulatory function in morbidly obese individuals after gastric bypass-induced weight loss: relation to alterations in endocannabinoids and adipocytokines. 204
Anti-apolipoprotein a-1 IgG levels predict coronary artery calcification in obese but otherwise healthy individuals. 197
Statins in the treatment of acute ischemic stroke. 189
Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice. 189
Impact of obesity and bariatric surgery on metabolism and coronary circulatory function. 188
Update on the Pathophysiological Activities of the Cardiac Molecule Cardiotrophin-1 in Obesity. 185
Coronary artery calcification and cardiovascular risk: the role of RANKL/OPG signalling. 181
Diagnostic value of PET-measured longitudinal flow gradient for the identification of coronary artery disease. 179
New evidence for nicotinic acid treatment to reduce atherosclerosis. 178
Update on the treatments of non-alcoholic fatty liver disease (NAFLD). 176
Inflammation in the pathophysiology of essential hypertension. 175
Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function 172
Coronary vasomotor control in obesity and morbid obesity: contrasting flow responses with endocannabinoids, leptin, and inflammation. 171
Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS). 168
Left atrial thrombosis in an anticoagulated patient after bioprosthetic valve replacement: Report of a case. 166
Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury 165
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 165
Heart failure and chronic kidney disease in a registry of internal medicine wards 165
Oxaprozin-induced apoptosis on CD40 ligand-treated human primary monocytes is associated with the modulation of defined intracellular pathways. 157
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 154
Intestinal radiation-induced stricture favours small bowel obstruction by phytobezoar: report of a case 153
Ezetimibe/simvastatin. 150
Quantitative PET/CT measures of myocardial flow reserve and atherosclerosis for cardiac risk assessment and predicting adverse patient outcomes. 147
The need of identifying circulating biomarkers of coronary dysfunction 147
Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. 146
RANKL/OPG pathway is a promising target to reduce atherosclerosis plaque calcification. 144
Effect of NH3 metabolite correction on the myocardial blood flow measurement. 144
Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome. 144
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 144
A Genetic Polymorphism in the Pannexin1 Gene Predisposes for The Development of Endothelial Dysfunction with Increasing BMI 142
Combined evaluation of myocardial perfusion and coronary morphology in the identification of subclinical CAD. Radiation exposure of 13N-ammonia PET/CT. 141
Improvement in Coronary Endothelial Function is Independently Associated with a Slowed Progression of Coronary Artery Calcification in Type 2 Diabetes Mellitus. 140
Structural epicardial disease and microvascular function are determinants of an abnormal longitudinal myocardial blood flow difference in cardiovascular risk individuals as determined with PET/CT. 139
Matching between regional coronary vasodilator capacity and corresponding circumferential strain in individuals with normal and increasing body weight. 136
Role of neutrophils in acute myocardial infarction. 132
The influence of insulin resistance, obesity, and diabetes mellitus on vascular tone and myocardial blood flow. 128
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 127
Quantitative assessment of myocardial blood flow--clinical and research applications. 124
Left ventricular dyssynchrony assessment by phase analysis from gated myocardial perfusion SPECT: moving beyond conventional criteria. 124
Plasma concentrations of edocannabinoid are associated with dysfunction of the coronary microcirculation in obese subjects. 117
Inter and intra operator variability of myocardial blood flow quantification using dynamic NH3 and Rb PET. 117
Inferior vena cava parameters predict readmission in ischemic heart failure. 117
Relationship between HDL Cholesterol Efflux Capacity, Calcium Coronary Artery Content, and Antibodies against ApolipoproteinA-1 in Obese and Healthy Subjects 117
New evidences for a direct involvement of neutrophils in atherosclerosis. 112
PET-Determined Hyperemic Longitudinal, Myocardial Flow Gradient as Noninvasive Probe of Epicardial Vasomotion in Cardiovascular Risk Individuals with or Without Coronary Artery Calcifications. 111
Receptor activator of NF-kappa B ligand (RANKL) increases neutrophilic degranulation and potentially associated cardiovascular risk. 110
Effect of gastric bypass on vasomotor function of the coronary circulation in morbid obese individuals without cardiovascular diseases. 108
Statin Treatment Is Associated with Reduction in Serum Levels of Receptor Activator of NF-kappaB Ligand and Neutrophil Activation in Patients with Severe Carotid Stenosis. 107
Novel treatment strategy with direct renin inhibition against heart failure. 97
Sulphasalazin accelerates apoptosis in neutrophils exposed to immune complex: role of caspase pathway. 96
Plasma palmitoylethanolamide as potential predictor of coronary dysfunction. 76
Mechanisms underlying endothelial dysfunction in obstructive sleep apnea syndrome (OSAS) patients. 72
Totale 8.918
Categoria #
all - tutte 27.539
article - articoli 26.526
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.013
Totale 55.078


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022625 0 0 26 89 54 50 61 160 20 58 29 78
2022/2023518 77 42 8 30 61 93 1 34 79 2 80 11
2023/2024293 10 46 8 41 21 75 16 18 15 5 7 31
2024/20251.029 19 70 24 51 196 128 135 135 44 37 81 109
2025/20261.962 197 67 177 228 214 167 318 46 103 179 106 160
2026/2027328 195 44 89 0 0 0 0 0 0 0 0 0
Totale 8.918